The invention relates generally to an accommodating intraocular lens device and, more particularly, to an accommodating intraocular lens device configured for implantation in a lens capsule or suclus of a subject's eye.
Surgical procedures on the eye have been on the rise as technological advances permit for sophisticated interventions to address a wide variety of ophthalmic conditions. Patient acceptance has increased over the last twenty years as such procedures have proven to be generally safe and to produce results that significantly improve patient quality of life.
Cataract surgery remains one of the most common surgical procedures, with over 16 million cataract procedures being performed worldwide. It is expected that this number will continue to increase as average life expectancies continue to rise. Cataracts are typically treated by removing the crystalline lens from the eye and implanting an intraocular lens (“IOL”) in its place. As conventional IOL devices are primarily focused for distance visions, they fail to correct for presbyopia and reading glasses are still required. Thus, while patients who undergo a standard IOL implantation no longer experience clouding from cataracts, they are unable to accommodate, or change focus from near to far, from far to near, and to distances in between.
Surgeries to correct refractive errors of the eye have also become extremely common, of which LASIK enjoys substantial popularity with over 700,000 procedures being performed per year. Given the high prevalence of refractive errors and the relative safety and effectiveness of this procedure, more and more people are expected to turn to LASIK or other surgical procedures over conventional eyeglasses or contact lens. Despite the success of LASIK in treating myopia, there remains an unmet need for an effective surgical intervention to correct for presbyopia, which cannot be treated by conventional LASIK procedures.
As nearly every cataract patient also suffers from presbyopia, there is convergence of market demands for the treatment of both these conditions. While there is a general acceptance among physicians and patients of having implantable intraocular lens in the treatment of cataracts, similar procedures to correct for presbyopia represent only 5% of the U.S. cataract market. There is therefore a need to address both ophthalmic cataracts and/or presbyopia in the growing aging population.
The accommodating intraocular lens (IOL) described herein combine the power changing feature of a flexible membrane with a base lens. The power changing feature of the IOL is driven by fluid optics within a closed volume. One significant advantage of the IOL is that the closed volume that spaces apart the flexible membrane and the base lens maintains a substantially constant volume and avoids many of the problems associated with fluid optic IOLs which involve or require a changing volume, i.e., fluid being fed into the chamber from reservoirs. The many disadvantages exhibited by fluid optics requiring changing volumes include non-uniform power change and/or non-uniform buckling of the flexible membrane. The IOLs disclosed herein avoid such problems by maintaining a substantially constant or fixed volume and maintaining good optical quality throughout the range of power change. The fluid redistributes itself within a closed volume as the power changes. This design requires a significantly smaller volume of fluid than known IOL fluid optics that require a reservoir. An additional benefit of this invention by virtue of being a smaller IOL, is a reduction of biocompatibility issues associated with larger IOLs as well as reducing the incision size required to implant the lens. This results in faster healing and a more stable refraction.
The IOLs disclosed herein may be configured in any number of ways. In one embodiment, the radially compressive forces exerted on an implanted IOL may be concentrated onto the flexible membrane to cause the flexible membrane to change in curvature. At the same time, the IOL is configured such that the radially compressive forces are minimized or reduced with respect to the optic. The optic, however, may be configured to axially displace toward the flexible membrane in response to its change in curvature. This axial displacement may be facilitated by coupling the optic to the peripheral edge of the IOL in a manner that permits the optic to float. As the flexible membrane changes in curvature, fluid adhesion or surface tension will operate to pull the optic toward the flexible membrane. Preferably, the optic resists or does not change in curvature.
In another embodiment, the radially compressive forces exerted on the implanted IOL may be concentrated onto the optic to cause the optic to axially displace. In a preferred embodiment, the optic resists or does not itself change in curvature. At the same time, the IOL is configured such that the radially compressive forces are minimized or reduced with respect to the flexible membrane. The flexible membrane, however, will change in curvature in response to the axial displacement of the lens.
In a further embodiment, the radially compressive forces exerted on the implanted IOL may be applied to both the flexible membrane and the optic to cause the change in curvature of the flexible membrane and the axial displacement of the optic toward the flexible membrane, while at the same time maintaining a constant volume of the space therebetween. Preferably, the flexible membrane changes in curvature while the optic is axially displaced and resists or does not change in curvature.
With respect to any of the embodiments, the thickness of the membrane may be uniform or it may be varied. In one embodiment, the membrane may have a thinner central region and a thicker peripheral region, about the central axis A-A, which may permit a larger power change for a given amount of force. However, if the ratio of thicknesses of the central to the peripheral regions of the membrane is too large, significant asphericity may result, reducing the optical quality under compression and making it more difficult to manufacture. A thicker membrane in the center may make it easier to manufacture the IOL but may reduce the potential power change. The determination of the optimal membrane thickness and uniformity of thickness is determined to maximize power change and optical quality while minimizing manufacturing issues and cost. The membrane must also be thick enough to permit handling during the implantation procedure.
The two-part accommodating IOL devices disclosed herein provides for a number of advantages owing to its separate two-part construction. Implantation of the IOL device requires a significantly reduced incision size, as the two parts of the IOL device are implanted separately and thus significantly reducing the delivery profile for implantation. The reduced incision size provides for a number of advantages, including obviating the need for anesthesia and sutures to close the incision site and improved surgical outcomes.
Additionally, greater control is afforded with respect to adjusting the sizing and the power of the IOL during surgery. Implanting the base lens assembly into the lens capsule will provide the physician an impression as to the size of the patient's lens capsule and will thus help verify the correct size of the power changing lens that will subsequently be implanted.
In one embodiment, an accommodating IOL is described. The IOL comprises an optic, a flexible membrane and a peripheral edge coupled to the optic and the flexible membrane. The peripheral edge comprises an external circumferential surface having a height and a force transmitting area defined along a portion of the height of the external circumferential surface. A closed volume spaces apart the optic and the flexible membrane. Preferably, the optic is axially displaced and the flexible membrane changes in curvature about a central axis when a radial compressive force is applied to the force transmitting area. The optic has greater rigidity than the membrane such that the optic resists bending or changing in curvature when the optic is axially displaced and/or when the radial compressive force is applied to the force transmitting area. Alternatively the IOL can be implanted into the sulcus. The IOL can be designed so that it could be implanted into the sulcus of an eye with or without the natural crystalline lens (phakic or pseudophakic IOL).
In accordance with a first aspect, the force transmitting area is a circumferential ring. Preferably, the circumferential ring protrudes outwardly from the circumferential peripheral edge.
In accordance with a second aspect, a fluid is contained within the closed volume. Preferably, the fluid is selected from the group consisting of: silicone oil, fluorinated silicone oil and polyphenyl ether.
In accordance with a third aspect, the accommodating IOL further comprises a haptic is in contact with or coupled to the force transmitting area.
In accordance with a fourth aspect, the closed volume is defined between the optic, the flexible membrane and the peripheral edge.
In accordance with a fifth aspect, a volume defined by the closed volume remains fixed when the optic is axially displaced and the flexible membrane changes in curvature and/or when the radial compressive force is applied to the force transmitting area.
In another embodiment, a two-piece accommodating intraocular lens assembly is described. The two-piece accommodating intraocular lens assembly comprises a base lens assembly and the accommodating IOL described herein. The base assembly comprises a base power optic and a haptic system circumferentially around the base power optic. The haptic system comprises an internal surface facing the base power optic and defining an internal space within which the accommodating IOL is removably maintained.
In accordance with a first aspect, only the force transmitting area of the external circumferential surface is in contact with the internal surface of the haptic system.
In accordance with a second aspect, the base lens assembly further comprises supporting flanges extending radially inwardly from the internal surface to contact a side of the IOL that comprises the optic and/or the flexible membrane.
In accordance with a third aspect, a plurality of spaced notches is disposed around an external surface of the haptic system.
In accordance with a fourth aspect, the base power optic may either partially or completely resist changes in curvature or may change in curvature in response to a radially compressive force applied to the haptic system.
In a further embodiment, an accommodating IOL is described. The accommodating IOL comprises an optic, a flexible membrane, and a circumferential peripheral edge comprising internal and external sides. A closed volume spaces apart the optic and the flexible membrane. An optic coupler and a membrane coupler are disposed from the internal side of the circumferential peripheral edge. A force transmitting area is disposed on the external side of the circumferential peripheral edge. The force transmitting area is located along a portion of the external side that opposes the optic coupler and is not located along a portion of the external side that opposes the membrane coupler. The force transmitting area concentrates the transmission of a radially compressive force applied thereon to the optic via the optic coupler to cause axial displacement of the optic along a central axis. Axial displacement of the optic causes a change in curvature of the flexible membrane as a result of the closed volume and adhesion of the fluid to the membrane.
In accordance with a first aspect, the force transmitting area is a circumferential ring. Preferably, the circumferential ring protrudes outwardly from the circumferential peripheral edge.
In accordance with a second aspect, a fluid is contained within the closed volume. Preferably, the fluid is selected from the group consisting of: silicone oil, fluorinated silicone oil and polyphenyl ether.
In accordance with a third aspect, the optic has greater rigidity than the membrane such that the optic resists bending or changing in curvature when the optic is axially displaced and/or when the radial compressive force is applied to the force transmitting area.
In accordance with a fourth aspect, a circumferential channel is defined between the internal side of the circumferential peripheral edge and the flexible membrane, the circumferential channel having an internal volume that is included within the closed volume.
In accordance with a fifth aspect, a haptic is in direct contact with or coupled to the force transmitting area.
In accordance with a sixth aspect, the closed volume is defined between the optic, the flexible membrane and the circumferential peripheral edge.
In accordance with a seventh aspect, the volume of the closed volume remains fixed when the radially compressive force is applied to the force transmitting area.
In yet a further embodiment, a two-piece accommodating intraocular lens assembly is described. The two-piece accommodating intraocular lens assembly comprises a base lens assembly and the accommodating IOL described here. The base assembly comprises a base power optic and a haptic system circumferentially around the base power optic, the haptic system having an internal surface defining an internal space within which the accommodating IOL is removably maintained.
In accordance with a first aspect, only the force transmitting area of the external side is in contact with the internal surface of the haptic system.
In accordance with a second aspect, the base lens assembly further comprises supporting flanges extending radially inwardly from the internal surface to contact a side of the IOL that comprises the optic and/or the flexible membrane.
In accordance with a third aspect, a plurality of spaced notches is disposed around an external surface of the haptic system.
In accordance with a fourth aspect, the base power optic may either partially or completely resist changes in curvature or may change in curvature in response to a radially compressive force applied to the haptic system.
In another embodiment, an accommodating IOL comprises an optic, a flexible membrane and a circumferential peripheral edge comprising internal and external sides. A closed volume provides a space between the optic and the flexible membrane. An optic coupler and a membrane coupler are each disposed from the internal side of the circumferential peripheral edge. A force transmitting area is disposed on the external side of the circumferential peripheral edge, the force transmitting area being located along a portion of the external side that opposes the membrane coupler and not being located along a portion of the external side that opposes the optic coupler. The force transmitting area concentrates the transmission of a radially compressive force applied thereon to the flexible membrane via the membrane coupler to cause a change in curvature of the flexible membrane about a central axis. A change in curvature of the flexible membrane causes a corresponding axial displacement of the optic as a result of the closed volume and adhesion of the fluid to the optic.
In accordance with a first aspect, the force transmitting area is a circumferential ring. Preferably, the circumferential ring protrudes outwardly from the circumferential peripheral edge.
In accordance with a second aspect, a fluid is contained within the closed volume. Preferably, the fluid is selected from the group consisting of: silicone oil, fluorinated silicone oil and polyphenyl ether.
In accordance with a third aspect, the optic coupler comprises a plurality of folded areas to permit the optic to freely displace axially along a central axis in response to the changes in curvature of the flexible membrane and/or when the radially compressive force is applied to the force transmitting area.
In accordance with a fourth aspect, a haptic is in direct contact with or coupled to the force transmitting area.
In accordance with a fifth aspect, the closed volume is defined between the optic, the flexible membrane and the circumferential peripheral edge.
In accordance with a sixth aspect, the closed volume remains fixed when the radially compressive force is applied to the force transmitting area.
In yet another embodiment, a two-piece accommodating intraocular lens assembly is described. The two-piece accommodating intraocular lens assembly comprises a base lens assembly and the accommodating IOL described herein. The base assembly comprises a base power optic and a haptic system circumferentially around the base power optic. The haptic system defines an internal space within which the accommodating IOL is removably maintained.
In accordance with a first aspect, only the force transmitting area of the external side is in contact with an internal surface of the haptic system.
In accordance with a second aspect, the base lens assembly further comprises supporting flanges extending radially inwardly from the internal surface to contact a side of the IOL that comprises the optic and/or the flexible membrane.
In accordance with a third aspect, a plurality of spaced notches disposed around an external surface of the haptic system.
In accordance with a fourth aspect, the base power optic may either partially or completely resist changes in curvature or may change in curvature in response to a radially compressive force applied to the haptic system.
In yet a further embodiment, an accommodating IOL is provided. The IOL comprises an optic, a flexible membrane and a force transmitting area coupled to the optic and the flexible membrane. A closed volume spaces apart the optic and the flexible membrane. The optic is axially displaced and the flexible membrane changes in curvature about a central axis when a radial compressive force is applied to the force transmitting area. The optic has greater rigidity than the membrane such that the optic resists bending or changing in curvature when the optic is axially displaced and/or when the radial compressive force is applied to the force transmitting area.
Other objects, features and advantages of the described preferred embodiments will become apparent to those skilled in the art from the following detailed description. It is to be understood, however, that the detailed description and specific examples, while indicating preferred embodiments of the present invention, are given by way of illustration and not limitation. Many changes and modifications within the scope of the present invention may be made without departing from the spirit thereof, and the invention includes all such modifications.
Illustrative embodiments of the present disclosure are described herein with reference to the accompanying drawings, in which:
Like numerals refer to like parts throughout the several views of the drawings.
Specific, non-limiting embodiments of the present invention will now be described with reference to the drawings. It should be understood that such embodiments are by way of example and are merely illustrative of but a small number of embodiments within the scope of the present invention. Various changes and modifications obvious to one skilled in the art to which the present invention pertains are deemed to be within the spirit, scope and contemplation of the present invention as further defined in the appended claims.
The contents of the following commonly-owned and co-pending U.S. patent applications are incorporated herein by reference as if fully set forth herein: U.S. patent application Ser. No. 13/662,087, filed Oct. 26, 2012, published as U.S. Pub. No. 2013/0053954 on Feb. 28, 2013; U.S. patent application Ser. No. 13/725,895, filed Dec. 21, 2012, published as U.S. Pub. No. 2014/0180403 on Jun. 26, 2014; U.S. Patent Appl. Ser. No. 61/899,110, filed Nov. 1, 2013 and U.S. Patent Appl. Ser. No. 61/899,106, filed Nov. 1, 2013.
As illustrated in
The force transmitting area 18 in the IOL 10 in
The force transmitting area 58 in the IOL 50 of
The circumferential peripheral edge 106 comprises at least two areas. A force transmitting area 108 and a stepped-in area 110. The force transmitting area 108 is intended to contact and engage the lens capsule or sulcus of an eye when implanted directly into the lens capsule or sulcus or contact the internal surface 422 of the base lens assembly 400 when used as part of a two-piece accommodating intraocular lens assembly (see
A closed volume 103 is provided within the IOL 100 to space apart the flexible membrane 102 and the optic 104. The closed volume 103 is not in fluid communication externally of the IOL 100 and therefore its volume remains fixed. As a result of the fixed volume and the vaulting of the optic 104 toward the flexible membrane 102 by the optic coupler 114, the flexible membrane 102 and the optic 104 do not diverge away from one another substantially when radially compressive forces are applied to the force transmitting area 108. The extension of the closed volume 103 beyond the circumference of the optic 104 functions to further isolate the optic 104 from directly experiencing the radially compressive forces exerted on the force transmitting area 108.
The change in curvature of the flexible membrane 102 provides the accommodative power change, with radially compressive force. As the flexible membrane 102 changes in curvature, the optic 104 axially displaces toward the flexible membrane 102. This permits the flexible membrane 102 to change shape in an optically uniform manner with a constant volume of fluid, thereby avoiding the problems of non-uniform buckling of the flexible membrane. The dotted lines in
As with the IOL 100 of
The change in curvature of the flexible membrane 202 provides the accommodative power change, with radially compressive force. As the flexible membrane 202 changes in curvature, the optic 204 axially displaces toward the flexible membrane 202. This permits the flexible membrane 202 to change shape in an optically uniform manner with a constant volume of fluid, thereby avoiding the problems of non-uniform buckling of the flexible membrane. The dotted lines in
The peripheral edge 306 comprises a force transmitting area 308 and a stepped-in area 310. Unlike the configuration of the peripheral edges shown in
In contrast to the embodiments depicted in
In one preferred embodiment, the IOL 300 further comprises a circumferential channel 305 that is in fluid communication with and included with the volume defining the closed volume 303. The circumferential channel 305 is provided between the internal side of the circumferential peripheral edge 306 and the flexible membrane 302 and functions to further isolate the flexible membrane 302 from the direct radially compressive forces exerted on the peripheral edge 306 and/or the force transmitting area 308 such that the changes in curvature of the flexible membrane 302 results substantially, if not entirely, as a direct result of the fluid pressure from the axial displacement of the optic 304.
The change in curvature of the flexible membrane 302 provides the accommodative power change, with radially compressive force. As the optic 304 axially displaces towards the flexible membrane 302, the flexible membrane 302 changes in curvature. This permits the flexible membrane 302 to change shape in an optically uniform manner with a constant volume of fluid, thereby avoiding the problems of non-uniform buckling of the flexible membrane. The dotted lines in
The fluid contained within the closed volumes 103, 203, and 303 of
In accordance with another embodiment, the fluid may be a fluorinated polyphenyl ether (“FPPE”). FPPE has the unique advantage of providing tunability of the refractive index while being a chemically inert, biocompatible fluid with dispersion properties. The tunability is provided by the increasing or decreasing the phenyl and fluoro content of the polymer. Increasing the phenyl content will effectively increase the refractive index of the FPPE, whereas increasing the fluoro content will decrease the refractive index of the FPPE while decreasing the permeability of the FPPE fluid through the walls of the IOL.
In another preferred embodiment, closed volume may be filled with a gel. The gel preferably has a refractive index of at least 1.46, 1.47, 1.48, or 1.49. The gel may also preferably have a Young's modulus of 20 psi or less, 10 psi or less, 4 psi or less, 1 psi or less, 0.5 psi or less, 0.25 psi or less and 0.01 psi or less. In a preferred embodiment, the gel is a crosslinked polymer, preferably a crosslinked silicone polymer, and more preferably a crosslinked phenyl siloxane polymer, such as a vinyl-terminated phenyl siloxane polymer or a vinyl-terminated diphenyl siloxane polymer. Other optically clear polymer liquids or gels, in addition to siloxane polymers, may be used to fill the enclosed cavity and such polymers may be branched, unbranched, crosslinked or uncrosslinked or any combination of the foregoing.
A gel has the advantages of being extended in molecular weight from being crosslinked, more self-adherent and also adherent to the walls or opposing sides of the IOL than most liquids. This makes a gel less likely to leak through the walls of the IOL. In order to obtain the combination of accommodative power with relatively small deformations in the curvature of the power changing lens, the gel is selected so as to have a high refractive index while being made of an optically clear material that is characterized as having a low Young's modulus. Thus, in a preferred embodiment, the gel has a refractive index of 1.46 or greater, preferably 1.47 or greater, 1.48 or greater and most preferably 1.49 or greater. At the same time, the gel preferably has a Young's modulus of 10 psi or less, preferably 5 psi or less, and more preferably 1 psi or less. In a particularly preferred embodiment, the gel has a Young's modulus of 0.5 psi or less, preferably 0.25 psi or less, and most preferably 0.01 psi or less. It is understood that at lower Young's modulus, the gel will present less resistance to deformation and thus the greater the deformation of the power changing lens 110 for a given unit of applied force.
The IOLs described in
Implantation of the two-piece accommodating intraocular lens assembly may be performed in two steps, with implantation of the base assembly 400 being performed first and implantation and assembly of the IOL within the base assembly 400 being subsequently performed. The advantage to this two-step process is the reduction in the incision size required to implant a lens that has a substantially greater range of accommodation. Moreover, the two-step process also provides flexibility with respect to providing one of two orientations of the IOL, the first of which positions the flexible membrane anteriorly of the eye and the second of which positions the flexible membrane posteriorly of the eye. The clinician may determine and choose the appropriate orientation based on the visual needs of a patient. Additionally the base assembly after implantation may be used to determine the size and power of the IOL that will be implanted.
An IOL similar to the IOL shown in
The IOL in Example 1 was built using an optic quality silicone material for the membrane and the closed volume was filled with a silicone fluid having a refractive index of 1.49. Testing was performed with an artificial capsule under similar load configuration in Example 1. The diopter power change measured using a 3 mm aperture was 5.5 D. The power changed from 23 D to 28.5 D with acceptable optical quality throughout the range of power change.
The IOL tested in Example 2 was then placed inside of a base lens assembly that was placed inside of an artificial lens capsule. The base lens assembly was similar in design to the lens shown in
The invention described and claimed herein is not to be limited in scope by the specific preferred embodiments disclosed herein, as these embodiments are intended as illustrations of several aspects of the invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims.
The present application is a continuation of U.S. patent application Ser. No. 16/002,850, filed on Jun. 7, 2018, which is a continuation of U.S. patent application Ser. No. 14/447,621, filed on Jul. 31, 2014, the contents of each of which are incorporated herein by reference in their entireties into the present disclosure.
Number | Name | Date | Kind |
---|---|---|---|
4032502 | Lee et al. | Jun 1977 | A |
4073014 | Poler | Feb 1978 | A |
4118808 | Poler | Oct 1978 | A |
4373218 | Schachar | Feb 1983 | A |
4512040 | McClure | Apr 1985 | A |
4585457 | Kalb | Apr 1986 | A |
4676791 | LeMaster et al. | Jun 1987 | A |
4720286 | Bailey et al. | Jan 1988 | A |
4731078 | Stoy et al. | Mar 1988 | A |
4822360 | Deacon | Apr 1989 | A |
4842601 | Smith | Jun 1989 | A |
4882368 | Elias et al. | Nov 1989 | A |
4888012 | Horn et al. | Dec 1989 | A |
4892543 | Turley | Jan 1990 | A |
4932966 | Christie et al. | Jul 1990 | A |
5035710 | Nakada et al. | Jul 1991 | A |
5059668 | Fukuda et al. | Oct 1991 | A |
5074876 | Kelman | Dec 1991 | A |
5091121 | Nakada et al. | Feb 1992 | A |
5152788 | Isaacson et al. | Oct 1992 | A |
5167883 | Takemasa et al. | Dec 1992 | A |
5171773 | Chaffe et al. | Dec 1992 | A |
5227447 | Sato et al. | Jul 1993 | A |
5236970 | Christ et al. | Aug 1993 | A |
5264522 | Mize et al. | Nov 1993 | A |
5275623 | Sarfarazi | Jan 1994 | A |
5278258 | Gerace et al. | Jan 1994 | A |
5312860 | Mize et al. | May 1994 | A |
5326506 | Vanderbilt | Jul 1994 | A |
5336487 | Refojo et al. | Aug 1994 | A |
5443506 | Garabet | Aug 1995 | A |
5447987 | Sato et al. | Sep 1995 | A |
5489302 | Skottun | Feb 1996 | A |
5583178 | Oxman et al. | Dec 1996 | A |
5607472 | Thompson | Mar 1997 | A |
5665794 | Maxson et al. | Sep 1997 | A |
5854310 | Maxson | Dec 1998 | A |
6071439 | Bawa et al. | Jun 2000 | A |
6117171 | Skottun | Sep 2000 | A |
6197057 | Peyman et al. | Mar 2001 | B1 |
6200342 | Tassignon | Mar 2001 | B1 |
6200581 | Lin et al. | Mar 2001 | B1 |
6201091 | Halloran et al. | Mar 2001 | B1 |
6361561 | Huo et al. | Mar 2002 | B1 |
6551354 | Ghazizadeh et al. | Apr 2003 | B1 |
6616691 | Tran | Sep 2003 | B1 |
6695881 | Peng et al. | Feb 2004 | B2 |
6730123 | Klopotek | May 2004 | B1 |
6797004 | Brady et al. | Sep 2004 | B1 |
6836374 | Esch et al. | Dec 2004 | B2 |
6855164 | Glazier | Feb 2005 | B2 |
6858040 | Nguyen et al. | Feb 2005 | B2 |
6860601 | Shadduck | Mar 2005 | B2 |
6881225 | Okada | Apr 2005 | B2 |
6926736 | Peng et al. | Aug 2005 | B2 |
6930838 | Schachar | Aug 2005 | B2 |
6935743 | Shadduck | Aug 2005 | B2 |
6966649 | Shadduck | Nov 2005 | B2 |
6969403 | Peng et al. | Nov 2005 | B2 |
6991651 | Portney | Jan 2006 | B2 |
7041134 | Nguyen et al. | May 2006 | B2 |
7063723 | Ran | Jun 2006 | B2 |
7068439 | Esch et al. | Jun 2006 | B2 |
7122053 | Esch | Oct 2006 | B2 |
7150760 | Zhang | Dec 2006 | B2 |
7217288 | Esch et al. | May 2007 | B2 |
7220279 | Nun | May 2007 | B2 |
7223288 | Zhang et al. | May 2007 | B2 |
7226478 | Ting et al. | Jun 2007 | B2 |
7229475 | Glazier | Jun 2007 | B2 |
7238201 | Portney et al. | Jul 2007 | B2 |
7247168 | Esch et al. | Jul 2007 | B2 |
7261737 | Esch et al. | Aug 2007 | B2 |
7264351 | Shadduck | Sep 2007 | B2 |
7276619 | Kunzler et al. | Oct 2007 | B2 |
7278739 | Shadduck | Oct 2007 | B2 |
7316713 | Zhang | Jan 2008 | B2 |
7416562 | Gross | Aug 2008 | B2 |
7438723 | Esch | Oct 2008 | B2 |
7452377 | Watling et al. | Nov 2008 | B2 |
7453646 | Lo | Nov 2008 | B2 |
7455691 | Feingold et al. | Nov 2008 | B2 |
7485144 | Esch | Feb 2009 | B2 |
7591849 | Richardson | Sep 2009 | B2 |
7637947 | Smith et al. | Dec 2009 | B2 |
7662179 | Sarfarazi | Feb 2010 | B2 |
7675686 | Lo et al. | Mar 2010 | B2 |
7753953 | Yee | Jul 2010 | B1 |
7776088 | Shadduck | Aug 2010 | B2 |
7780729 | Nguyen et al. | Aug 2010 | B2 |
7815678 | Nun | Oct 2010 | B2 |
7842087 | Nun | Nov 2010 | B2 |
7854764 | Nun | Dec 2010 | B2 |
7857850 | Mentak et al. | Dec 2010 | B2 |
7918886 | Aharoni et al. | Apr 2011 | B2 |
7981155 | Cumming | Jul 2011 | B2 |
7985253 | Cumming | Jul 2011 | B2 |
7986465 | Lo et al. | Jul 2011 | B1 |
7998198 | Angelopoulos et al. | Aug 2011 | B2 |
7998199 | Nun | Aug 2011 | B2 |
8012204 | Weinschenk, III et al. | Sep 2011 | B2 |
8018658 | Lo | Sep 2011 | B2 |
8034106 | Mentak et al. | Oct 2011 | B2 |
8034107 | Stenger | Oct 2011 | B2 |
8038711 | Clarke | Oct 2011 | B2 |
8048155 | Shadduck | Nov 2011 | B2 |
8052752 | Woods et al. | Nov 2011 | B2 |
8062361 | Nguyen et al. | Nov 2011 | B2 |
8066768 | Werblin | Nov 2011 | B2 |
8066769 | Werblin | Nov 2011 | B2 |
8070806 | Khoury | Dec 2011 | B2 |
8158712 | Your | Apr 2012 | B2 |
8182531 | Hermans et al. | May 2012 | B2 |
8187325 | Zadno-Azizi et al. | May 2012 | B2 |
8197541 | Schedler | Jun 2012 | B2 |
8216306 | Coroneo | Jul 2012 | B2 |
8246679 | Nguyen et al. | Aug 2012 | B2 |
8254034 | Shields et al. | Aug 2012 | B1 |
8257827 | Shi et al. | Sep 2012 | B1 |
8273123 | Nun | Sep 2012 | B2 |
8303656 | Shadduck | Nov 2012 | B2 |
8308800 | Chu | Nov 2012 | B2 |
8314927 | Choi et al. | Nov 2012 | B2 |
8320049 | Huang et al. | Nov 2012 | B2 |
8328869 | Smiley et al. | Dec 2012 | B2 |
8361145 | Scholl et al. | Jan 2013 | B2 |
8377124 | Hong et al. | Feb 2013 | B2 |
8377125 | Kellan | Feb 2013 | B2 |
8398709 | Nun | Mar 2013 | B2 |
8414646 | De Juan, Jr. et al. | Apr 2013 | B2 |
8425597 | Glick et al. | Apr 2013 | B2 |
8425599 | Shadduck | Apr 2013 | B2 |
8430928 | Liao | Apr 2013 | B2 |
8447086 | Hildebrand et al. | May 2013 | B2 |
8454688 | Esch et al. | Jun 2013 | B2 |
8475529 | Clarke | Jul 2013 | B2 |
8491651 | Tsai et al. | Jul 2013 | B2 |
8496701 | Hermans et al. | Jul 2013 | B2 |
8500806 | Phillips | Aug 2013 | B1 |
8518026 | Culbertson et al. | Aug 2013 | B2 |
8545556 | Woods et al. | Oct 2013 | B2 |
8579972 | Rombach | Nov 2013 | B2 |
8585758 | Woods | Nov 2013 | B2 |
8603167 | Rombach | Dec 2013 | B2 |
8608799 | Blake | Dec 2013 | B2 |
8608800 | Portney | Dec 2013 | B2 |
8613766 | Richardson et al. | Dec 2013 | B2 |
8647384 | Lu | Feb 2014 | B2 |
8657810 | Culbertson et al. | Feb 2014 | B2 |
8657878 | Mentak et al. | Feb 2014 | B2 |
8668734 | Hildebrand et al. | Mar 2014 | B2 |
8690942 | Hildebrand et al. | Mar 2014 | B2 |
8715345 | DeBoer et al. | May 2014 | B2 |
8715346 | De Juan, Jr. et al. | May 2014 | B2 |
8734509 | Mentak et al. | May 2014 | B2 |
8771347 | DeBoer et al. | Jul 2014 | B2 |
8814934 | Geraghty et al. | Aug 2014 | B2 |
8834565 | Nun | Sep 2014 | B2 |
8834566 | Jones | Sep 2014 | B1 |
8858626 | Noy | Oct 2014 | B2 |
8867141 | Pugh et al. | Oct 2014 | B2 |
8900298 | Anvar et al. | Dec 2014 | B2 |
8900300 | Wortz | Dec 2014 | B1 |
8920495 | Mirlay | Dec 2014 | B2 |
8956408 | Smiley et al. | Feb 2015 | B2 |
8968396 | Matthews et al. | Mar 2015 | B2 |
8968399 | Ghabra | Mar 2015 | B2 |
8992609 | Shadduck | Mar 2015 | B2 |
9005282 | Chang et al. | Apr 2015 | B2 |
9005283 | Nguyen et al. | Apr 2015 | B2 |
9034035 | Betser et al. | May 2015 | B2 |
9044317 | Hildebrand et al. | Jun 2015 | B2 |
9072600 | Tran | Jul 2015 | B2 |
9090033 | Carson et al. | Jul 2015 | B2 |
9095424 | Kahook et al. | Aug 2015 | B2 |
9125736 | Kahook et al. | Sep 2015 | B2 |
9149356 | Sarfarazi | Oct 2015 | B2 |
9186244 | Silvestrini et al. | Nov 2015 | B2 |
9198752 | Woods | Dec 2015 | B2 |
9277987 | Smiley et al. | Mar 2016 | B2 |
9277988 | Chu | Mar 2016 | B1 |
9289287 | Kahook et al. | Mar 2016 | B2 |
9326846 | Devita Gerardi et al. | May 2016 | B2 |
9333072 | Ichikawa | May 2016 | B2 |
9358103 | Wortz et al. | Jun 2016 | B1 |
9364316 | Kahook et al. | Jun 2016 | B1 |
9387069 | Kahook et al. | Jul 2016 | B2 |
9398949 | Werblin | Jul 2016 | B2 |
9421088 | Kahook et al. | Aug 2016 | B1 |
9427312 | DeBoer et al. | Aug 2016 | B2 |
9433497 | DeBoer et al. | Sep 2016 | B2 |
9456895 | Shadduck | Oct 2016 | B2 |
9486311 | Argento et al. | Nov 2016 | B2 |
9610155 | Matthews | Apr 2017 | B2 |
9622852 | Simonov et al. | Apr 2017 | B2 |
9629712 | Stenger | Apr 2017 | B2 |
9636213 | Brady | May 2017 | B2 |
9655716 | Cumming | May 2017 | B2 |
9681946 | Kahook et al. | Jun 2017 | B2 |
9693858 | Hildebrand et al. | Jul 2017 | B2 |
9713526 | Rombach | Jul 2017 | B2 |
9713527 | Nishi et al. | Jul 2017 | B2 |
9717589 | Simonov et al. | Aug 2017 | B2 |
9744027 | Jansen | Aug 2017 | B2 |
9744028 | Simonov et al. | Aug 2017 | B2 |
9795472 | Culbertson et al. | Oct 2017 | B2 |
9795473 | Smiley et al. | Oct 2017 | B2 |
9808339 | Dorronsoro Diaz et al. | Nov 2017 | B2 |
9814568 | Ben Nun | Nov 2017 | B2 |
9814570 | Robert et al. | Nov 2017 | B2 |
9820849 | Jansen | Nov 2017 | B2 |
9848980 | McCafferty | Dec 2017 | B2 |
9855137 | Smiley et al. | Jan 2018 | B2 |
9855139 | Matthews et al. | Jan 2018 | B2 |
9861469 | Simonov et al. | Jan 2018 | B2 |
9872762 | Scholl et al. | Jan 2018 | B2 |
9872763 | Smiley et al. | Jan 2018 | B2 |
9877825 | Kahook et al. | Jan 2018 | B2 |
9883940 | Nishi et al. | Feb 2018 | B2 |
9925039 | Sohn et al. | Mar 2018 | B2 |
9925040 | Kahook et al. | Mar 2018 | B2 |
9931202 | Borja et al. | Apr 2018 | B2 |
9987126 | Borja et al. | Jun 2018 | B2 |
10004596 | Brady et al. | Jun 2018 | B2 |
10010405 | Hayes | Jul 2018 | B2 |
10028824 | Kahook et al. | Jul 2018 | B2 |
10039635 | Wanders | Aug 2018 | B2 |
10045844 | Smiley et al. | Aug 2018 | B2 |
10080648 | Kahook et al. | Sep 2018 | B2 |
10080649 | Zhang et al. | Sep 2018 | B2 |
10111745 | Silvestrini et al. | Oct 2018 | B2 |
10159562 | Cady | Dec 2018 | B2 |
10159564 | Brady et al. | Dec 2018 | B2 |
10195017 | Culbertson et al. | Feb 2019 | B2 |
10195018 | Salahieh et al. | Feb 2019 | B2 |
10195020 | Matthews | Feb 2019 | B2 |
10285805 | De Juan, Jr. et al. | May 2019 | B2 |
10299910 | Cady | May 2019 | B2 |
10299913 | Smiley et al. | May 2019 | B2 |
10327886 | Sohn et al. | Jun 2019 | B2 |
10350056 | Argento et al. | Jul 2019 | B2 |
10363129 | Ghabra et al. | Jul 2019 | B2 |
10368979 | Scholl et al. | Aug 2019 | B2 |
10390937 | Smiley et al. | Aug 2019 | B2 |
10433949 | Smiley et al. | Oct 2019 | B2 |
10463473 | Rombach et al. | Nov 2019 | B2 |
10526353 | Silvestrini | Jan 2020 | B2 |
10548719 | Pallikaris et al. | Feb 2020 | B2 |
10647831 | Silvestrini et al. | May 2020 | B2 |
10772721 | Rao et al. | Sep 2020 | B2 |
10842614 | Cady | Nov 2020 | B2 |
10842616 | Silvestrini et al. | Nov 2020 | B2 |
10888219 | Smith et al. | Jan 2021 | B2 |
10905547 | Auld et al. | Feb 2021 | B2 |
10912676 | Schaller et al. | Feb 2021 | B2 |
10917543 | Luna et al. | Feb 2021 | B2 |
10945832 | Cady | Mar 2021 | B2 |
10959836 | Qureshi et al. | Mar 2021 | B2 |
10980629 | Anvar et al. | Apr 2021 | B2 |
10987183 | Brennan et al. | Apr 2021 | B2 |
11000363 | Campin et al. | May 2021 | B2 |
11000364 | Brady et al. | May 2021 | B2 |
11000367 | Wu et al. | May 2021 | B2 |
11026838 | Raksi | Jun 2021 | B2 |
11039901 | Tripathi | Jun 2021 | B2 |
11040477 | Chauvin et al. | Jun 2021 | B2 |
11045309 | Kahook et al. | Jun 2021 | B2 |
11046490 | Cerveny | Jun 2021 | B2 |
11051884 | Tripathi et al. | Jul 2021 | B2 |
11065107 | Brady et al. | Jul 2021 | B2 |
11065109 | Argento et al. | Jul 2021 | B2 |
11065152 | Kelleher et al. | Jul 2021 | B2 |
11071449 | Heeren | Jul 2021 | B2 |
11071622 | Matthews | Jul 2021 | B2 |
11076948 | Kahook et al. | Aug 2021 | B2 |
11083567 | Honigsbaum | Aug 2021 | B2 |
11109957 | Cady | Sep 2021 | B2 |
11109960 | Borja et al. | Sep 2021 | B2 |
11110005 | Diao et al. | Sep 2021 | B2 |
11111055 | Reece et al. | Sep 2021 | B2 |
11141263 | Argento et al. | Oct 2021 | B2 |
11162065 | Fachin et al. | Nov 2021 | B2 |
11166808 | Smiley et al. | Nov 2021 | B2 |
11166844 | Charles | Nov 2021 | B2 |
11173008 | Mirsepassi et al. | Nov 2021 | B2 |
11213606 | Jiang et al. | Jan 2022 | B2 |
11224540 | Sivadas | Jan 2022 | B2 |
11298221 | McCulloch | Apr 2022 | B2 |
20020005344 | Heidlas et al. | Jan 2002 | A1 |
20020055776 | Juan, Jr. et al. | May 2002 | A1 |
20020071856 | Dillingham et al. | Jun 2002 | A1 |
20020120329 | Lang et al. | Aug 2002 | A1 |
20020138140 | Hanna | Sep 2002 | A1 |
20030060881 | Glick et al. | Mar 2003 | A1 |
20030093149 | Glazier | May 2003 | A1 |
20030105522 | Glazier | Jun 2003 | A1 |
20030109926 | Portney | Jun 2003 | A1 |
20030149480 | Shadduck | Aug 2003 | A1 |
20030158295 | Fukuda et al. | Aug 2003 | A1 |
20030204254 | Peng et al. | Oct 2003 | A1 |
20030204256 | Peng et al. | Oct 2003 | A1 |
20040015236 | Sarfarazi | Jan 2004 | A1 |
20040082993 | Woods | Apr 2004 | A1 |
20040082994 | Woods et al. | Apr 2004 | A1 |
20040111152 | Kelman | Jun 2004 | A1 |
20040148023 | Shu | Jul 2004 | A1 |
20040162612 | Portney et al. | Aug 2004 | A1 |
20040169816 | Esch | Sep 2004 | A1 |
20040169932 | Esch | Sep 2004 | A1 |
20040249455 | Tran | Dec 2004 | A1 |
20050021139 | Shadduck | Jan 2005 | A1 |
20050071002 | Glazier | Mar 2005 | A1 |
20050107873 | Zhou | May 2005 | A1 |
20050119740 | Esch | Jun 2005 | A1 |
20050137703 | Chen | Jun 2005 | A1 |
20050149183 | Shadduck | Jul 2005 | A1 |
20050251253 | Gross | Nov 2005 | A1 |
20050251254 | Brady et al. | Nov 2005 | A1 |
20050267575 | Nguyen et al. | Dec 2005 | A1 |
20060041307 | Esch et al. | Feb 2006 | A1 |
20060047339 | Brown | Mar 2006 | A1 |
20060069178 | Rastogi et al. | Mar 2006 | A1 |
20060074487 | Gilg | Apr 2006 | A1 |
20060100701 | Esch | May 2006 | A1 |
20060111776 | Glick et al. | May 2006 | A1 |
20060134173 | Liu et al. | Jun 2006 | A1 |
20060135477 | Haitjema et al. | Jun 2006 | A1 |
20060212116 | Woods | Sep 2006 | A1 |
20060238702 | Glick et al. | Oct 2006 | A1 |
20060241752 | Israel | Oct 2006 | A1 |
20060271186 | Nishi et al. | Nov 2006 | A1 |
20070016293 | Tran | Jan 2007 | A1 |
20070032868 | Woods | Feb 2007 | A1 |
20070050024 | Zhang | Mar 2007 | A1 |
20070050025 | Nguyen et al. | Mar 2007 | A1 |
20070078515 | Brady et al. | Apr 2007 | A1 |
20070088433 | Esch et al. | Apr 2007 | A1 |
20070100445 | Shadduck | May 2007 | A1 |
20070106377 | Smith | May 2007 | A1 |
20070118216 | Pynson | May 2007 | A1 |
20070129798 | Chawdhary | Jun 2007 | A1 |
20070129799 | Schedler | Jun 2007 | A1 |
20070129800 | Cumming | Jun 2007 | A1 |
20070129801 | Cumming | Jun 2007 | A1 |
20070132949 | Phelan | Jun 2007 | A1 |
20070156236 | Stenger | Jul 2007 | A1 |
20070213817 | Esch et al. | Sep 2007 | A1 |
20070260308 | Tran | Nov 2007 | A1 |
20070260310 | Richardson | Nov 2007 | A1 |
20080015689 | Esch et al. | Jan 2008 | A1 |
20080033547 | Chang et al. | Feb 2008 | A1 |
20080046074 | Smith et al. | Feb 2008 | A1 |
20080046075 | Esch et al. | Feb 2008 | A1 |
20080046077 | Cumming | Feb 2008 | A1 |
20080051886 | Lin | Feb 2008 | A1 |
20080154364 | Richardson et al. | Jun 2008 | A1 |
20080200982 | Your | Aug 2008 | A1 |
20080269887 | Cumming | Oct 2008 | A1 |
20080300680 | Nun | Dec 2008 | A1 |
20080306587 | Your | Dec 2008 | A1 |
20080306588 | Smiley et al. | Dec 2008 | A1 |
20080306589 | Donitzky et al. | Dec 2008 | A1 |
20090005865 | Smiley et al. | Jan 2009 | A1 |
20090027661 | Choi et al. | Jan 2009 | A1 |
20090043384 | Niwa | Feb 2009 | A1 |
20090116118 | Frazier et al. | May 2009 | A1 |
20090125106 | Weinschenk, III et al. | May 2009 | A1 |
20090149952 | Shadduck | Jun 2009 | A1 |
20090198326 | Zhou et al. | Aug 2009 | A1 |
20090204209 | Tran | Aug 2009 | A1 |
20090204210 | Pynson | Aug 2009 | A1 |
20090264998 | Mentak et al. | Oct 2009 | A1 |
20090292355 | Boyd et al. | Nov 2009 | A1 |
20090319040 | Khoury | Dec 2009 | A1 |
20100004742 | Cumming | Jan 2010 | A1 |
20100055449 | Ota | Mar 2010 | A1 |
20100057095 | Khuray et al. | Mar 2010 | A1 |
20100094412 | Wensrich | Apr 2010 | A1 |
20100094413 | Rombach et al. | Apr 2010 | A1 |
20100131058 | Shadduck | May 2010 | A1 |
20100131059 | Callahan et al. | May 2010 | A1 |
20100179653 | Argento et al. | Jul 2010 | A1 |
20100204787 | Noy | Aug 2010 | A1 |
20100211169 | Stanley et al. | Aug 2010 | A1 |
20100228344 | Shadduck | Sep 2010 | A1 |
20100288346 | Esch | Sep 2010 | A1 |
20100324672 | Esch et al. | Dec 2010 | A1 |
20100324674 | Brown | Dec 2010 | A1 |
20110029074 | Reisin et al. | Feb 2011 | A1 |
20110071628 | Gross et al. | Mar 2011 | A1 |
20110118834 | Lo et al. | May 2011 | A1 |
20110118836 | Jain | May 2011 | A1 |
20110208301 | Anvar et al. | Aug 2011 | A1 |
20110224788 | Webb | Sep 2011 | A1 |
20110264209 | Wiechmann et al. | Oct 2011 | A1 |
20110282442 | Scholl et al. | Nov 2011 | A1 |
20110288638 | Smiley et al. | Nov 2011 | A1 |
20120016473 | Brady et al. | Jan 2012 | A1 |
20120035724 | Clarke | Feb 2012 | A1 |
20120071972 | Zhao | Mar 2012 | A1 |
20120078364 | Stenger | Mar 2012 | A1 |
20120095125 | Hu et al. | Apr 2012 | A1 |
20120150292 | Mentak et al. | Jun 2012 | A1 |
20120232649 | Cuevas | Sep 2012 | A1 |
20120245683 | Christie et al. | Sep 2012 | A1 |
20120253458 | Geraghty et al. | Oct 2012 | A1 |
20120253459 | Reich et al. | Oct 2012 | A1 |
20120290084 | Coroneo | Nov 2012 | A1 |
20120296423 | Caffey | Nov 2012 | A1 |
20120296424 | Betser | Nov 2012 | A1 |
20120310341 | Simonov et al. | Dec 2012 | A1 |
20120310343 | Van Noy | Dec 2012 | A1 |
20130006353 | Betser et al. | Jan 2013 | A1 |
20130035760 | Portney | Feb 2013 | A1 |
20130038944 | Chang et al. | Feb 2013 | A1 |
20130040073 | Pett et al. | Feb 2013 | A1 |
20130060331 | Shadduck | Mar 2013 | A1 |
20130110234 | DeVita et al. | May 2013 | A1 |
20130110235 | Shweigerling | May 2013 | A1 |
20130116781 | Nun | May 2013 | A1 |
20130131794 | Smiley et al. | May 2013 | A1 |
20130190867 | Peyman | Jul 2013 | A1 |
20130231741 | Clarke | Sep 2013 | A1 |
20130250239 | Hildebrand et al. | Sep 2013 | A1 |
20130268070 | Esch et al. | Oct 2013 | A1 |
20130297018 | Brady et al. | Nov 2013 | A1 |
20130317607 | DeBoer et al. | Nov 2013 | A1 |
20130317608 | Hermans et al. | Nov 2013 | A1 |
20140012277 | Matthews et al. | Jan 2014 | A1 |
20140058507 | Reich et al. | Feb 2014 | A1 |
20140085726 | Portney | Mar 2014 | A1 |
20140100654 | Portney et al. | Apr 2014 | A1 |
20140107459 | Lind et al. | Apr 2014 | A1 |
20140111765 | DeBoer et al. | Apr 2014 | A1 |
20140121768 | Simpson | May 2014 | A1 |
20140135917 | Glazier | May 2014 | A1 |
20140135918 | De Juan, Jr. et al. | May 2014 | A1 |
20140142558 | Culbertson et al. | May 2014 | A1 |
20140172089 | Lee et al. | Jun 2014 | A1 |
20140172092 | Carson et al. | Jun 2014 | A1 |
20140180403 | Silvestrini | Jun 2014 | A1 |
20140180404 | Tram | Jun 2014 | A1 |
20140180405 | Weinschenk, III et al. | Jun 2014 | A1 |
20140180406 | Simpson | Jun 2014 | A1 |
20140180407 | Sohn et al. | Jun 2014 | A1 |
20140180410 | Gerardi | Jun 2014 | A1 |
20140227437 | DeBoer et al. | Aug 2014 | A1 |
20140228949 | Argento | Aug 2014 | A1 |
20140249625 | Shadduck | Sep 2014 | A1 |
20140257478 | McCafferty | Sep 2014 | A1 |
20140257479 | McCafferty | Sep 2014 | A1 |
20140296977 | Culbertson et al. | Oct 2014 | A1 |
20140309734 | Sohn et al. | Oct 2014 | A1 |
20150087743 | Anvar et al. | Mar 2015 | A1 |
20150105760 | Rao et al. | Apr 2015 | A1 |
20150127102 | Wortz | May 2015 | A1 |
20150173892 | Borja et al. | Jun 2015 | A1 |
20150202041 | Shadduck | Jul 2015 | A1 |
20150216652 | Jansen | Aug 2015 | A1 |
20150230980 | Culbertson et al. | Aug 2015 | A1 |
20150238310 | Matthews et al. | Aug 2015 | A1 |
20150327991 | Hayes | Nov 2015 | A1 |
20150342728 | Simonov et al. | Dec 2015 | A1 |
20150359625 | Argal et al. | Dec 2015 | A1 |
20150366656 | Wortz et al. | Dec 2015 | A1 |
20160000558 | Honigsbaum | Jan 2016 | A1 |
20160008126 | Salahieh et al. | Jan 2016 | A1 |
20160051361 | Phillips | Feb 2016 | A1 |
20160058553 | Salahieh et al. | Mar 2016 | A1 |
20160074154 | Woods | Mar 2016 | A1 |
20160106534 | Deboer et al. | Apr 2016 | A1 |
20160113761 | Nishi et al. | Apr 2016 | A1 |
20160184089 | Dudee et al. | Jun 2016 | A1 |
20160184092 | Smiley et al. | Jun 2016 | A1 |
20160208138 | Nishijima et al. | Jul 2016 | A1 |
20160256265 | Borja et al. | Sep 2016 | A1 |
20160262875 | Smith et al. | Sep 2016 | A1 |
20160281019 | Deklippel et al. | Sep 2016 | A1 |
20160287380 | Shi et al. | Oct 2016 | A1 |
20160317287 | Silvestrini et al. | Nov 2016 | A1 |
20160361157 | Honigsbaum | Dec 2016 | A1 |
20170020662 | Shadduck | Jan 2017 | A1 |
20170049561 | Smiley et al. | Feb 2017 | A1 |
20170049562 | Argento et al. | Feb 2017 | A1 |
20170100234 | Culbertson et al. | Apr 2017 | A1 |
20170216021 | Brady | Aug 2017 | A1 |
20170247525 | Silvestrini et al. | Aug 2017 | A1 |
20170290658 | Hildebrand et al. | Oct 2017 | A1 |
20170319332 | Kahook et al. | Nov 2017 | A1 |
20170348095 | Wortz et al. | Dec 2017 | A1 |
20180014928 | Kahook et al. | Jan 2018 | A1 |
20180028308 | Smiley et al. | Feb 2018 | A1 |
20180085211 | Culbertson et al. | Mar 2018 | A1 |
20180110613 | Wortz et al. | Apr 2018 | A1 |
20180125640 | Smiley et al. | May 2018 | A1 |
20180132997 | Smiley et al. | May 2018 | A1 |
20180147051 | Scholl et al. | May 2018 | A1 |
20180153682 | Hajela et al. | Jun 2018 | A1 |
20180161152 | Argento et al. | Jun 2018 | A1 |
20180161153 | Kahook et al. | Jun 2018 | A1 |
20180177589 | Argento et al. | Jun 2018 | A1 |
20180177639 | Rao et al. | Jun 2018 | A1 |
20180185139 | Sohn et al. | Jul 2018 | A1 |
20180256315 | Hildebrand et al. | Sep 2018 | A1 |
20180271642 | Wortz et al. | Sep 2018 | A1 |
20180271645 | Brady et al. | Sep 2018 | A1 |
20180280135 | Otts | Oct 2018 | A1 |
20180296323 | Olcina Portilla | Oct 2018 | A1 |
20180307061 | State et al. | Oct 2018 | A1 |
20180318068 | Otts et al. | Nov 2018 | A1 |
20180344453 | Brady | Dec 2018 | A1 |
20180360659 | Culbertson et al. | Dec 2018 | A1 |
20180368971 | Zacher et al. | Dec 2018 | A1 |
20180368973 | Wortz et al. | Dec 2018 | A1 |
20180368974 | Kahook et al. | Dec 2018 | A1 |
20190000612 | Rao et al. | Jan 2019 | A1 |
20190015198 | Kuiper | Jan 2019 | A1 |
20190021848 | Kahook et al. | Jan 2019 | A1 |
20190069989 | Otts et al. | Mar 2019 | A1 |
20190076239 | Wortz et al. | Mar 2019 | A1 |
20190076241 | Alarcon Heredia et al. | Mar 2019 | A1 |
20190076243 | Hadba et al. | Mar 2019 | A1 |
20190083235 | Wortz | Mar 2019 | A1 |
20190099263 | Brady et al. | Apr 2019 | A1 |
20190269499 | Ellis | Sep 2019 | A1 |
20190269500 | De Juan, Jr. et al. | Sep 2019 | A1 |
20190274823 | Argento et al. | Sep 2019 | A1 |
20190358025 | Smiley et al. | Nov 2019 | A1 |
20190374333 | Shadduck | Dec 2019 | A1 |
20190374334 | Brady et al. | Dec 2019 | A1 |
20200000577 | Smiley et al. | Jan 2020 | A1 |
20200054445 | Rosen et al. | Feb 2020 | A1 |
20200085568 | Brady et al. | Mar 2020 | A1 |
20200129287 | Culbertson et al. | Apr 2020 | A1 |
20200138564 | Culbertson et al. | May 2020 | A1 |
20200157124 | Silvestrini | May 2020 | A1 |
20200261217 | Dudee | Aug 2020 | A1 |
20200337833 | Green | Oct 2020 | A1 |
20200345481 | Ellis | Nov 2020 | A1 |
20200369853 | Silvestrini et al. | Nov 2020 | A1 |
20200397562 | Cady | Dec 2020 | A1 |
20210007554 | Byun et al. | Jan 2021 | A1 |
20210015303 | Byun et al. | Jan 2021 | A1 |
20210015359 | Goldshleger et al. | Jan 2021 | A1 |
20210030530 | Smiley et al. | Feb 2021 | A1 |
20210038373 | Collins et al. | Feb 2021 | A1 |
20210063767 | Hong et al. | Mar 2021 | A1 |
20210093447 | Heckler, II et al. | Apr 2021 | A1 |
20210100649 | Smiley | Apr 2021 | A1 |
20210100650 | Smiley et al. | Apr 2021 | A1 |
20210100652 | Walz et al. | Apr 2021 | A1 |
20210113327 | Auld et al. | Apr 2021 | A1 |
20210128195 | Abt | May 2021 | A1 |
20210128516 | Cheng et al. | May 2021 | A1 |
20210128800 | Chon et al. | May 2021 | A1 |
20210154957 | Olson et al. | May 2021 | A1 |
20210191153 | Borja et al. | Jun 2021 | A1 |
20210191154 | Borja et al. | Jun 2021 | A1 |
20210196890 | Appy et al. | Jul 2021 | A1 |
20210196893 | Appy et al. | Jul 2021 | A1 |
20210196894 | Appy et al. | Jul 2021 | A1 |
20210196900 | Appy et al. | Jul 2021 | A1 |
20210205134 | Rao et al. | Jul 2021 | A1 |
20210220067 | Charles | Jul 2021 | A1 |
20210228333 | Hubschman et al. | Jul 2021 | A1 |
20210244488 | Carbone et al. | Aug 2021 | A1 |
20210251718 | Tripathi | Aug 2021 | A1 |
20210259827 | Brady et al. | Aug 2021 | A1 |
20210282920 | Cady | Sep 2021 | A1 |
20210284944 | Grandhi et al. | Sep 2021 | A1 |
20210290369 | Cady | Sep 2021 | A1 |
20210290370 | Cady | Sep 2021 | A1 |
20210290371 | Anvar et al. | Sep 2021 | A1 |
20210290374 | Kahook et al. | Sep 2021 | A1 |
20210291469 | Zheng et al. | Sep 2021 | A1 |
20210292557 | Cheng et al. | Sep 2021 | A1 |
20210292558 | Bassampour et al. | Sep 2021 | A1 |
20210297560 | Luna et al. | Sep 2021 | A1 |
20210302625 | Cheng et al. | Sep 2021 | A1 |
20210315688 | Matthews | Oct 2021 | A1 |
20210322151 | Kahook et al. | Oct 2021 | A1 |
20210322219 | Raksi | Oct 2021 | A1 |
20210361415 | Borja et al. | Nov 2021 | A1 |
20210369106 | Campin et al. | Dec 2021 | A1 |
20210369446 | Taber et al. | Dec 2021 | A1 |
20210371150 | Leibold et al. | Dec 2021 | A1 |
20210401570 | Brady et al. | Dec 2021 | A1 |
20220000606 | Cady | Jan 2022 | A1 |
20220015946 | Hallen et al. | Jan 2022 | A1 |
20220047383 | Brady et al. | Feb 2022 | A1 |
Number | Date | Country |
---|---|---|
1064611 | Sep 1992 | CN |
102186438 | Sep 2011 | CN |
102271623 | Dec 2011 | CN |
20 2010 003217 | Aug 2011 | DE |
0356050 | Feb 1990 | EP |
0766540 | Aug 1999 | EP |
1 852 090 | Jan 2009 | EP |
1 859 760 | Apr 2010 | EP |
2 451 380 | Mar 2014 | EP |
2 473 137 | Mar 2014 | EP |
2 111 822 | Aug 2014 | EP |
1881818 | Jul 2015 | EP |
2 512 374 | Nov 2015 | EP |
2 501 336 | Sep 2016 | EP |
3 049 023 | Jun 2017 | EP |
3 035 889 | Feb 2019 | EP |
3 171 821 | Mar 2020 | EP |
3 463 186 | Aug 2020 | EP |
3 003 217 | Oct 2020 | EP |
3 782 584 | Feb 2021 | EP |
3 651 693 | May 2021 | EP |
3 197 396 | Sep 2021 | EP |
3 888 595 | Oct 2021 | EP |
3 932 367 | Jan 2022 | EP |
3 946 155 | Feb 2022 | EP |
H09-150002 | Jun 1997 | JP |
2005-511201 | Apr 2005 | JP |
2006-511245 | Apr 2006 | JP |
2006-516002 | Jun 2006 | JP |
2007-313326 | Dec 2007 | JP |
2010-514507 | May 2010 | JP |
2011-526822 | Oct 2011 | JP |
2013-047290 | Mar 2013 | JP |
WO 9217132 | Oct 1992 | WO |
WO 9929266 | Jun 1999 | WO |
WO 1999056670 | Nov 1999 | WO |
WO 2000021467 | Apr 2000 | WO |
WO 2001034067 | May 2001 | WO |
WO 2004037127 | May 2004 | WO |
WO 2004052242 | Jun 2004 | WO |
WO 2004054471 | Jul 2004 | WO |
WO 2004072689 | Aug 2004 | WO |
WO 2006047383 | May 2006 | WO |
WO 2007005778 | Jan 2007 | WO |
WO 2007047529 | Apr 2007 | WO |
WO 2007047530 | Apr 2007 | WO |
WO 2008024766 | Feb 2008 | WO |
WO 2008031231 | Mar 2008 | WO |
WO 2008077040 | Jun 2008 | WO |
WO 2008082957 | Jul 2008 | WO |
WO 2008103798 | Aug 2008 | WO |
WO 2009015161 | Jan 2009 | WO |
WO 2009015226 | Jan 2009 | WO |
WO 2009015234 | Jan 2009 | WO |
WO 2009015240 | Jan 2009 | WO |
WO 2009064876 | May 2009 | WO |
WO 2010010565 | Jan 2010 | WO |
WO 2010081093 | Jul 2010 | WO |
WO 2011026068 | Mar 2011 | WO |
WO 2011106435 | Sep 2011 | WO |
WO 2011137191 | Nov 2011 | WO |
WO 2012006616 | Jan 2012 | WO |
WO 2012129407 | Sep 2012 | WO |
WO 2013016804 | Feb 2013 | WO |
WO 2013070924 | May 2013 | WO |
WO 2013142323 | Sep 2013 | WO |
WO 2013166068 | Nov 2013 | WO |
WO 2013180254 | Dec 2013 | WO |
WO 2013190130 | Dec 2013 | WO |
WO 2014099630 | Jun 2014 | WO |
WO 2014145562 | Sep 2014 | WO |
WO 2014152017 | Sep 2014 | WO |
WO 2014197170 | Dec 2014 | WO |
WO 2015066502 | May 2015 | WO |
WO 2015066532 | May 2015 | WO |
WO 2015126604 | Aug 2015 | WO |
WO 2015148673 | Oct 2015 | WO |
WO 2016018932 | Feb 2016 | WO |
WO 2016033217 | Mar 2016 | WO |
WO 2016049059 | Mar 2016 | WO |
WO 2016122805 | Aug 2016 | WO |
WO 2016201351 | Dec 2016 | WO |
WO 2017079449 | May 2017 | WO |
WO 2017079733 | May 2017 | WO |
WO 2017087358 | May 2017 | WO |
WO 2017096087 | Jun 2017 | WO |
WO 2017192855 | Nov 2017 | WO |
WO 2017205811 | Nov 2017 | WO |
WO 2018081595 | May 2018 | WO |
WO 2018119408 | Jun 2018 | WO |
WO 2018167099 | Sep 2018 | WO |
WO 2018222579 | Dec 2018 | WO |
WO 2018227014 | Dec 2018 | WO |
WO 2019005859 | Jan 2019 | WO |
WO 2019027845 | Feb 2019 | WO |
WO 2019089515 | May 2019 | WO |
WO 2019236908 | Dec 2019 | WO |
WO 2021092222 | May 2021 | WO |
WO 2021119174 | Jun 2021 | WO |
WO 2021126451 | Jun 2021 | WO |
Entry |
---|
International Search Report and Written Opinion dated Oct. 26, 2015 for PCT/US2015/042513. (10 pages). |
Ehrmann, et al., “Biomechanical analysis of the accommodative apparatus in primates”, Clinical and Experimental Optometry, May 2008, vol. 91, Issue 3, pp. 302-312. |
Ehrmann, et al., “Ex Vivo Accommodation Simulator II—Concept and Preliminary Results”, Proceedings of SPIE vol. 5314, Ophthalmic Technologies XIV, Jul. 2004, pp. 48-58. |
Gabel, et al., “Silicone oil with high specific gravity for intraocular use”, British Journal of Ophthalmology, Apr. 1987, vol. 71, 262-267. |
Ghallagher-Wetmore, et al., “Supercritical fluid processing: a new dry technique for photoresist developing”, SPIE's 1995 Symposium on Microlithography, 1995, vol. 2438, 16 pages. |
Lane, et al., “Comparison of the biomechanical behavior of foldable intraocular lenses”, Journal of Cataract Refract Surg, Nov. 2004, vol. 30, pp. 2397-2402. |
Nakamura, et al., “Analysis and Fractionation of Silicone and Fluorosilicone Oils for Intraocular Use”, Investigative Ophthalmology & Visual Science, vol. 31, No. 10, Oct. 1990, 2059-2069. |
National Center for Biotechnology Information. PubChem Substance Database; SID=184590955, https://pubchem.ncbi.nlm.nih.gov/substance/184590955 (accessed Sep. 20, 2017). |
Zhang, et al., “Fluidic adaptive lens with high focal length tunability”, Applied Physics Letters, May 2003, vol. 82, No. 19, pp. 3171-3172. |
Zhang, et al., “Integrated fluidic adaptive zoom lens”, Optics Letters, Dec. 2004, vol. 29, No. 24, pp. 2855-2857. |
Zhao, et al., “Strategies for Supercritical CO2 Fractionation of Polydimethylsiloxane,” Journal of Applied Polymer Science, 1995, vol. 55, 773-778. |
Aliancy, et al., “Long-term capsule clarity with a disk-shaped intraocular lens”, Journal of Cataract & Refractive Surgery, Apr. 2018, vol. 44, Issue 4, pp. 504-509. |
Kramer, et al., “Prevention of postoperative capsular bag opacification using intraocular lenses and endocapsular devices maintaining an open or expanded capsular bag”, Journal of Cataract & Refractive Surgery, Mar. 2016, vol. 42, Issue 3, pp. 469-484. |
Leishman, et al., “Prevention of capsular bag opacification with a modified hydrophilic acrylic diskshaped intraocular lens”, Journal of Cataract & Refractive Surgery, Sep. 2012, vol. 38, Issue 9, pp. 1664-1670. |
Number | Date | Country | |
---|---|---|---|
20200179104 A1 | Jun 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16002850 | Jun 2018 | US |
Child | 16678318 | US | |
Parent | 14447621 | Jul 2014 | US |
Child | 16002850 | US |